{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:59:44Z","timestamp":1787065184276,"version":"build-2736575974"},"reference-count":23,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["2013-003798-82"],"award-info":[{"award-number":["2013-003798-82"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["62869767"],"award-info":[{"award-number":["62869767"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","award":["NIHR-HTA 11\/30\/07"],"award-info":[{"award-number":["NIHR-HTA 11\/30\/07"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["kidney-international.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.kint.2023.09.012","type":"journal-article","created":{"date-parts":[[2023,9,30]],"date-time":"2023-09-30T03:36:44Z","timestamp":1696045004000},"page":"200-208","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Evaluation of the stopping angiotensin converting enzyme inhibitor compared to angiotensin receptor blocker (STOP ACEi trial) in advanced and progressive chronic kidney disease"],"prefix":"10.1016","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0996-9622","authenticated-orcid":false,"given":"Sunil","family":"Bhandari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4690-3649","authenticated-orcid":false,"given":"Arif","family":"Khawaja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John G.F.","family":"Cleland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Ives","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Cockwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.kint.2023.09.012_bib1","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1053\/j.ajkd.2015.10.011","article-title":"Renin-angiotensin system inhibitors and kidney and cardiovascular outcomes in patients with CKD: a Bayesian network meta-analysis of randomised clinical trials","volume":"67","author":"Xie","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2023.09.012_bib2","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1053\/j.ajkd.2013.03.018","article-title":"KDOQI US commentary on the 2012 KDIGO clinical practice guideline for management of blood pressure in CKD","volume":"62","author":"Taler","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2023.09.012_bib3","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1056\/NEJMoa2210639","article-title":"Renin\u2013angiotensin system inhibition in advanced chronic kidney disease","volume":"387","author":"Bhandari","year":"2022","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2023.09.012_bib4","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1056\/NEJM199606203342507","article-title":"Angiotensin receptors and their antagonist","volume":"334","author":"Goodfriend","year":"1996","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2023.09.012_bib5","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1056\/NEJMoa042274","article-title":"Diabetics Exposed to Telmisartan and Enalapril Study Group. Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy","volume":"351","author":"Barnett","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.kint.2023.09.012_bib6","first-page":"CD006257","article-title":"Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists for preventing the progression of diabetic kidney disease","volume":"2006","author":"Strippoli","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.kint.2023.09.012_bib7","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/ndt\/gfx072","article-title":"Effect of renin\u2013angiotensin\u2013aldosterone system blockade in adults with diabetes mellitus and advanced chronic kidney disease not on dialysis: a systematic review and meta-analysis","volume":"33","author":"Nistor","year":"2018","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2023.09.012_bib8","first-page":"255","article-title":"Multicentre randomized controlled trial of angiotensin-converting enzyme inhibitor\/angiotensin receptor blocker withdrawal in advanced renal disease: the STOP-ACEi trial","volume":"31","author":"Bhandari","year":"2016","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2023.09.012_bib9","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1056\/NEJMc2302340","article-title":"Renin\u2013angiotensin system inhibition in advanced CKD","volume":"388","author":"Speth","year":"2023","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2023.09.012_bib10","first-page":"1438","article-title":"Renin\u2013angiotensin system inhibition in advanced CKD: reply","volume":"388","author":"Bhandari","year":"2023","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2023.09.012_bib11","first-page":"e197","article-title":"Comparison between three different equations for the estimation of glomerular filtration rate in Omani patients with type 2 diabetes mellitus","volume":"14","author":"Al-Maqbali","year":"2014","journal-title":"Sultan Qaboos Univ Med J"},{"key":"10.1016\/j.kint.2023.09.012_bib12","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1053\/j.ajkd.2019.06.009","article-title":"Change in albuminuria and GFR as end points for clinical trials in early stages of CKD: a scientific workshop sponsored by the National Kidney Foundation in collaboration with the US Food and Drug Administration and European Medicines Agency","volume":"75","author":"Levey","year":"2020","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2023.09.012_bib13","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s40265-020-01290-3","article-title":"ACE inhibitor benefit to kidney and cardiovascular outcomes for patients with non-dialysis chronic kidney disease stages 3\u20135: a network meta-analysis of randomised clinical trials","volume":"80","author":"Zhang","year":"2020","journal-title":"Drugs"},{"key":"10.1016\/j.kint.2023.09.012_bib14","doi-asserted-by":"crossref","first-page":"f6008","DOI":"10.1136\/bmj.f6008","article-title":"Comparative effectiveness of renin-angiotensin system blockers and other antihypertensive drugs in patients with diabetes: systematic review and Bayesian network meta-analysis","volume":"347","author":"Wu","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.kint.2023.09.012_bib15","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1161\/01.HYP.23.4.439","article-title":"Effects of converting enzyme inhibitors on angiotensin and bradykinin peptides","volume":"23","author":"Campbell","year":"1994","journal-title":"Hypertension"},{"key":"10.1016\/j.kint.2023.09.012_bib16","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/nrd873","article-title":"Drugs targeting the renin\u2013angiotensin\u2013aldosterone system","volume":"1","author":"Zaman","year":"2002","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.kint.2023.09.012_bib17","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1161\/01.CIR.0000096609.73772.C5","article-title":"Can angiotensin II type 2 receptors have deleterious effects in cardiovascular disease? implications for therapeutic blockade of the renin-angiotensin system","volume":"109","author":"Levy","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.kint.2023.09.012_bib18","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1161\/01.HYP.0000248196.14826.31","article-title":"Emerging concept of adipogenesis regulation by the renin-angiotensin system","volume":"48","author":"Mogi","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.kint.2023.09.012_bib19","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1161\/01.HYP.35.5.1074","article-title":"Angiotensin type 2 receptor mediates valsartan-induced hypotension in conscious rats","volume":"35","author":"Siragy","year":"2000","journal-title":"Hypertension"},{"key":"10.1016\/j.kint.2023.09.012_bib20","first-page":"1506","article-title":"Angiotensin II receptor blockers and coronary artery disease: \u201cpresumed innocents.\u201d","volume":"27","author":"Volpe","year":"2006"},{"key":"10.1016\/j.kint.2023.09.012_bib21","doi-asserted-by":"crossref","first-page":"C82","DOI":"10.1152\/ajpcell.00287.2006","article-title":"Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system","volume":"292","author":"Mehta","year":"2007","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.kint.2023.09.012_bib22","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1189\/jlb.1204715","article-title":"Angiotensin II increases human monocyte matrix metalloproteinase-1 through the AT2 receptor and prostaglandin E2: implications for atherosclerotic plaque rupture","volume":"78","author":"Kim","year":"2005","journal-title":"J\u00a0Leukoc Biol"},{"key":"10.1016\/j.kint.2023.09.012_bib23","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1016\/S0002-9440(10)64130-2","article-title":"Systemic infusion of angiotensin II into normal rats activates nuclear factor-\u03baB and AP-1 in the kidney","volume":"158","author":"Ruiz-Ortega","year":"2001","journal-title":"Am J Pathol"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253823006762?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253823006762?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T01:34:13Z","timestamp":1715132053000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253823006762"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S0085253823006762"],"URL":"https:\/\/doi.org\/10.1016\/j.kint.2023.09.012","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of the stopping angiotensin converting enzyme inhibitor compared to angiotensin receptor blocker (STOP ACEi trial) in advanced and progressive chronic kidney disease","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2023.09.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}